Peptides act as messengers (signalling molecules) that send signals to cells and tissues of the body to regulate their functions, such as releasing insulin, burning fat, or delaying digestion
Both ultimately raise endogenous growth hormone and IGF-1 levels, placing them mechanistically closer to Tesamorelin than to AOD-9604, which was specifically designed to avoid GH/IGF-1 involvement altogether
"KLOW 80mg" refers to the total peptide mass in one KLOW vial: 50mg BPC-157 + 10mg TB-500 + 10mg KPV + 10mg GHK-Cu = 80mg combined
BPC-157 promotes tissue and wound healing in skin and muscle
Tacconelli A, Farina AR, Cappabianca L, DeSantis G, Tessitore A, Vetuschi A, Sferra R, Rucci N, Argenti B, Screpanti I, et al
Some have read the studies themselves and dont want to wait for permission from the FDA